CBDHF — Hempfusion Wellness Income Statement
0.000.00%
Consumer DefensivesHighly SpeculativeMicro Cap
- $5.71m
- $1.05m
- $3.82m
Annual income statement for Hempfusion Wellness, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | ARS | ARS |
Standards: | IFRS | IFRS |
Status: | Final | Final |
Revenue | ||
Total Revenue | 3.02 | 3.82 |
Cost of Revenue | ||
Gross Profit | 0.613 | 0.4 |
Selling / General / Administrative Expenses | ||
Research And Development | ||
Depreciation and Amortization | ||
Unusual Expense / Income | ||
Total Operating Expenses | 15.3 | 30.3 |
Operating Profit | -12.3 | -26.5 |
Gain / Loss on Sale of Assets | ||
Total Net Non Operating Interest Income / Expense | ||
Other Net Non Operating Costs | ||
Net Income Before Taxes | -12.2 | -38 |
Provision for Income Taxes | ||
Net Income After Taxes | -12.2 | -38 |
Net Income Before Extraordinary Items | ||
Net Income | -12.2 | -38 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | -12.2 | -38 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | -0.104 | -0.262 |
Dividends per Share |